Pulmonary Hypertension News – Pulmonary Hypertension News
5 天之前 · Awareness campaign aims to improve PAH diagnosis, treatment. A new educational campaign aims to raise awareness of pulmonary arterial hypertension (PAH) symptoms, with the goal of accelerating diagnosis and improving treatment.
Pulmonary Arterial Pressure Above 30 mmHg Linked to Increased...
2019年7月8日 · An estimated right ventricular systolic pressure (eRVSP) — a measure of the pressure inside the artery that supplies blood to the lungs (pulmonary artery) — greater than 30.0 mmHg is related to an increased risk of mortality in patients with pulmonary hypertension (PH), according to a new Australian study.
Top 10 Pulmonary Hypertension Stories of 2022 | Key Topics:...
2022年12月29日 · Opsumit (macitentan) is a daily oral therapy that’s approved to treat pulmonary arterial hypertension (PAH). In this study, researchers analyzed data from the Phase 3 clinical trial SERAPHIN (NCT00660179) and its open-label extension (NCT00667823) to evaluate the therapy’s long-term effect on survival.Nearly three-quarters (73.3%) of patients were alive at five years, and more than half ...
Approval of new treatments for pulmonary hypertension prompts...
2024年4月3日 · First, in late March, the FDA approved a once-daily, fixed-dose tablet containing a combination of macitentan and tadalafil for adults with pulmonary arterial hypertension (PAH). It will be marketed under the brand name Opsynvi and is the first single-tablet treatment combination to become available to people with PAH in the U.S.. Then, just days later, the FDA approved the under-the-skin ...
Platelets get trapped in lungs in PH with right heart failure: Study
3 天之前 · Platelets, or cell fragments in blood that help stop or prevent bleeding, tend to cluster in lung blood vessels of people with decompensated pulmonary hypertension (PH), a lung disease characterized by sudden worsening of clinical signs of right heart failure, followed by other severe complications, a study has found.
Top 10 Pulmonary Hypertension Stories of 2021 – Pulmonary...
2022年1月3日 · The U.S. Food and Drug Administration (FDA), however, declined to approve Tyvaso DPI in October due to an inspection issue at a third-party manufacturing facility. United Therapeutics announced an intention to address this single issue. No. 6 – “Uptravi Found to Reduce Risk, by Half, of PAH Disease Progression“ The Phase 3 clinical trials GRIPHON (NCT01106014) and TRITON (NCT02558231 ...
In PH, dilated pulmonary artery is common: Large-scale study
2024年1月3日 · The clinical characteristics related to a dilated pulmonary artery, such as heart function and blood flow parameters, varied widely among the types of PH, but dilation wasn’t associated with an increased mortality risk, according to “ Pulmonary artery dilatation in different causes of pulmonary hypertension,” which was published in Pulmonary Circulation.
Breathing problems while sleeping linked to worsening PAH: Study
2023年12月4日 · People with pulmonary arterial hypertension (PAH) who have problems breathing while they’re sleeping — causing nocturnal hypoxemia, or oxygen levels in the blood to drop during the night — are nearly twice as likely as patients without such difficulty to experience clinical worsening, a study found.
Experts call for referral protocols to improve PH care
2023年7月5日 · Pulmonary hypertension (PH) experts are calling for care protocols to expedite patient referrals to specialists to make diagnoses and begin treatment sooner.. The importance of early referrals was a key topic during the recent International Meeting on Pulmonary Hypertension Clinical Treatment (IMPAHCT) in Barcelona, Spain.
Early Detection of PH Essential for Optimal Care: New Guidelines
2022年8月31日 · The guidelines provide more specific information about diagnosis and treatment for all of the types of PH.But they especially emphasize pulmonary arterial hypertension (PAH), a distinct vascular disorder characterized by PH, and chronic thromboembolic pulmonary hypertension (CTEPH) when PH develops due to blood clots in the lungs.. Over the last decade or two, care for PAH has improved ...